Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation

Abstract Amino acid replacement mutations in certain chronic lymphocytic leukemia (CLL) stereotyped B cell receptor (BCR) immunoglobulins (IGs) at defined positions within antigen-binding sites strongly imply antigen selection. Prime examples of this are CLL subset 4 BCR IGs using IGHV4-34/IGHD5-18/...

Full description

Bibliographic Details
Main Authors: Rosa Catera, Yun Liu, Chao Gao, Xiao-Jie Yan, Amanda Magli, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, Charles C. Chu, Ten Feizi, Kostas Stamatopoulos, Nicholas Chiorazzi
Format: Article
Language:English
Published: BMC 2017-01-01
Series:Molecular Medicine
Online Access:http://link.springer.com/article/10.2119/molmed.2017.00003
_version_ 1819053878594764800
author Rosa Catera
Yun Liu
Chao Gao
Xiao-Jie Yan
Amanda Magli
Steven L. Allen
Jonathan E. Kolitz
Kanti R. Rai
Charles C. Chu
Ten Feizi
Kostas Stamatopoulos
Nicholas Chiorazzi
author_facet Rosa Catera
Yun Liu
Chao Gao
Xiao-Jie Yan
Amanda Magli
Steven L. Allen
Jonathan E. Kolitz
Kanti R. Rai
Charles C. Chu
Ten Feizi
Kostas Stamatopoulos
Nicholas Chiorazzi
author_sort Rosa Catera
collection DOAJ
description Abstract Amino acid replacement mutations in certain chronic lymphocytic leukemia (CLL) stereotyped B cell receptor (BCR) immunoglobulins (IGs) at defined positions within antigen-binding sites strongly imply antigen selection. Prime examples of this are CLL subset 4 BCR IGs using IGHV4-34/IGHD5-18/IGHJ6 and IGKV2-30/IGKJ2 rearrangements. Conspicuously, and unlike most CLL IGs, subset 4 IGs do not bind apoptotic cells. By testing the (auto)antigenic reactivities of subset 4 IGs toward viable lymphoid-lineage cells and specific autoantigens typically bound by IGHV4-34+ IGs, we found that IGs from both subset 4 and non-subset 4 IGHV4-34-expressing CLL cases bound naïve B cells. However, only subset 4 IGs reacted with memory B cells. Furthermore, subset 4 IGs did not bind DNA nor i or I carbohydrate antigens that are common targets of IGHV4-34-utilizing antibodies in systemic lupus erythematosus and cold agglutinin disease, respectively. Notably, we found that subset 4 IG binding to memory B lymphocytes depends on an aspartic acid at position 66 of FR3 in the rearranged IGKV2-30 gene; this amino acid residue is acquired by somatic mutation. Our findings illustrate the importance of positive and negative selection criteria for structural elements in CLL IGs and suggest that autoantigens driving normal B cells to become subset 4 CLL cells differ from those driving IGHV4-34+ B cells in other diseases.
first_indexed 2024-12-21T12:42:44Z
format Article
id doaj.art-9e9c41d121d1407f8fb9aa6e622fb796
institution Directory Open Access Journal
issn 1076-1551
1528-3658
language English
last_indexed 2024-12-21T12:42:44Z
publishDate 2017-01-01
publisher BMC
record_format Article
series Molecular Medicine
spelling doaj.art-9e9c41d121d1407f8fb9aa6e622fb7962022-12-21T19:03:44ZengBMCMolecular Medicine1076-15511528-36582017-01-0123111210.2119/molmed.2017.00003Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic MutationRosa Catera0Yun Liu1Chao Gao2Xiao-Jie Yan3Amanda Magli4Steven L. Allen5Jonathan E. Kolitz6Kanti R. Rai7Charles C. Chu8Ten Feizi9Kostas Stamatopoulos10Nicholas Chiorazzi11Karches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyGlycosciences Laboratory, Department of Medicine, Imperial College LondonKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyGlycosciences Laboratory, Department of Medicine, Imperial College LondonInstitute of Applied Biosciences, Centre for Research and Technology-HellasKarches Center for Oncology Research, The Feinstein Institute for Medical Research, Experimental ImmunologyAbstract Amino acid replacement mutations in certain chronic lymphocytic leukemia (CLL) stereotyped B cell receptor (BCR) immunoglobulins (IGs) at defined positions within antigen-binding sites strongly imply antigen selection. Prime examples of this are CLL subset 4 BCR IGs using IGHV4-34/IGHD5-18/IGHJ6 and IGKV2-30/IGKJ2 rearrangements. Conspicuously, and unlike most CLL IGs, subset 4 IGs do not bind apoptotic cells. By testing the (auto)antigenic reactivities of subset 4 IGs toward viable lymphoid-lineage cells and specific autoantigens typically bound by IGHV4-34+ IGs, we found that IGs from both subset 4 and non-subset 4 IGHV4-34-expressing CLL cases bound naïve B cells. However, only subset 4 IGs reacted with memory B cells. Furthermore, subset 4 IGs did not bind DNA nor i or I carbohydrate antigens that are common targets of IGHV4-34-utilizing antibodies in systemic lupus erythematosus and cold agglutinin disease, respectively. Notably, we found that subset 4 IG binding to memory B lymphocytes depends on an aspartic acid at position 66 of FR3 in the rearranged IGKV2-30 gene; this amino acid residue is acquired by somatic mutation. Our findings illustrate the importance of positive and negative selection criteria for structural elements in CLL IGs and suggest that autoantigens driving normal B cells to become subset 4 CLL cells differ from those driving IGHV4-34+ B cells in other diseases.http://link.springer.com/article/10.2119/molmed.2017.00003
spellingShingle Rosa Catera
Yun Liu
Chao Gao
Xiao-Jie Yan
Amanda Magli
Steven L. Allen
Jonathan E. Kolitz
Kanti R. Rai
Charles C. Chu
Ten Feizi
Kostas Stamatopoulos
Nicholas Chiorazzi
Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
Molecular Medicine
title Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
title_full Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
title_fullStr Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
title_full_unstemmed Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
title_short Binding of CLL Subset 4 B Cell Receptor Immunoglobulins to Viable Human Memory B Lymphocytes Requires a Distinctive IGKV Somatic Mutation
title_sort binding of cll subset 4 b cell receptor immunoglobulins to viable human memory b lymphocytes requires a distinctive igkv somatic mutation
url http://link.springer.com/article/10.2119/molmed.2017.00003
work_keys_str_mv AT rosacatera bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT yunliu bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT chaogao bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT xiaojieyan bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT amandamagli bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT stevenlallen bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT jonathanekolitz bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT kantirrai bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT charlescchu bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT tenfeizi bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT kostasstamatopoulos bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation
AT nicholaschiorazzi bindingofcllsubset4bcellreceptorimmunoglobulinstoviablehumanmemoryblymphocytesrequiresadistinctiveigkvsomaticmutation